Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment.

scientific article

Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment. is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.1177/2324709618765893
P932PMC publication ID5871038
P698PubMed publication ID29619395

P50authorCatherine LangevinQ91692730
P2093author name stringPierre Poitras
Raymond Leduc
Hugo Chapdelaine
Jean-Maxime Picard
P2860cites workPharmacological management of Cronkhite-Canada syndromeQ35076597
Effectiveness of cyclosporine as a treatment for steroid-resistant Cronkhite-Canada syndrome; two case reportsQ36156548
Cronkhite-Canada syndrome presenting as eosinophilic gastroenteritis.Q36717979
Peutz-Jeghers syndrome: diagnostic and therapeutic approach.Q37422996
Cronkhite–Canada syndrome six decades on: the many faces of an enigmatic diseaseQ38227373
The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.Q38252815
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimenQ46299732
Use of sirolimus (rapamycin) to treat refractory Crohn's diseaseQ46417377
Everolimus for refractory Crohn's disease: a case reportQ46753802
Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity.Q53222444
P921main subjectsirolimusQ32089
Cronkhite-Canada syndromeQ1422034
P304page(s)2324709618765893
P577publication date2018-01-01
P1433published inJournal of investigative medicine high impact case reportsQ27725587
P1476titleSirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment.
P478volume6

Search more.